KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurora Cannabis (ACB) Cash & Equivalents (2018 - 2025)

Aurora Cannabis (ACB) has disclosed Cash & Equivalents for 2 consecutive years, with $96.1 million as the latest value for Q1 2025.

  • On a quarterly basis, Cash & Equivalents fell 4.83% to $96.1 million in Q1 2025 year-over-year; TTM through Mar 2025 was $96.1 million, a 4.83% decrease, with the full-year FY2025 number at $99.2 million, down 1.72% from a year prior.
  • Cash & Equivalents was $96.1 million for Q1 2025 at Aurora Cannabis, up from $94.9 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $101.1 million in Q2 2024 to a low of $78.9 million in Q3 2024.